DOT Privacy Program

table td { padding: 0px 0px 0px 0px; margin: 0px 0px 0px 0px; border: 0px !important; padding-bottom: 0px;} table{border: 0px !important}

This information is designed to help you understand the the U.S. Department of Transportation (DOT) personal information...

AV 3.0 Summit 3.1.2018

Safety For All Users Report

GPS Adjacent Band Compatibility Assessment Workshop IV

GPS Adjacent Band Compatibility Assessment Workshop V

GPS Adjacent Band Compatibility Assessment Workshop VI

USDOT Automated Vehicles 2.0 Activities

National Highway Traffic Safety Administration (NHTSA)

Automated Driving Systems: A Vision for Safety 2.0, September 12, 2017, Ann Arbor, Michigan

A Vision for Safety 2.0 calls for industry, state and local governments, safety and mobility advocates and the public to lay...

DOT Rule 49 CFR Part 40 Section 40.135 Q&A

§§ 40.135; 40.327 ...

Subsidized EAS report for non-Alaska communities-January 2018 (PDF)

DOT Drug Testing: Part 40 - Employee Notice

This is a reminder that the U.S. Department of Transportation (DOT) drug testing program will soon require testing for four semi-synthetic opioids (i.e., hydrocodone, oxycodone, hydromorphone, oxymorphone). The change is effective January 1, 2018.

What does this mean for...

Policy